Trial Profile
A comparative study of vildagliptin and other OAD in patients with T2DM inadequately controlled with current therapy
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2016
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 30 Sep 2016 New trial record